Moreover, for LC, elevated Siglec‐15 expression also indicated poor prognosis for both progression free survival (PFS, P = 5.7 × 10−9) and overall survival (OS, P = 0.00069) (Figure 3A,B). The gene discussed is SIGLEC15; the disease is laryngotracheoesophageal cleft.